HR 3797 116th Congress House Health Administrative law and regulatory procedures Alternative treatments Department of Health and Human Services Drug safety, medical device, and laboratory regulation Drug therapy Drug trafficking and controlled substances Food and Drug Administration (FDA) Health personnel Licensing and registrations Medical research Research administration and funding

Medical Marijuana Research Act

Introduced: July 17, 2019 See on congress.gov

Everywhere this bill has been 17 steps

Introduced

In committee

Reported out

Passed House

Passed Senate

To President

Became law

Dec 18, 2020

Read twice and referred to the Committee on the Judiciary.

Dec 10, 2020

Received in the Senate.

Dec 9, 2020

Motion to reconsider laid on the table Agreed to without objection.

Dec 9, 2020

On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H7076-7078)

Dec 9, 2020

Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.

Dec 9, 2020

DEBATE - The House proceeded with forty minutes of debate on H.R. 3797.

Dec 9, 2020

Considered under suspension of the rules. (consideration: CR H7076-7083)

Dec 9, 2020

Mr. Pallone moved to suspend the rules and pass the bill, as amended.

Dec 7, 2020

Placed on the Union Calendar, Calendar No. 508.

Dec 7, 2020

Committee on the Judiciary discharged.

Dec 7, 2020

Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-619, Part I.

Sep 9, 2020

Ordered to be Reported (Amended) by Voice Vote.

Sep 9, 2020

Committee Consideration and Mark-up Session Held.

Aug 6, 2019

Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.

Jul 18, 2019

Referred to the Subcommittee on Health.

Jul 17, 2019

Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Jul 17, 2019

Introduced in House

Plain-English summary Congressional Research Service

Medical Marijuana Research Act

This bill establishes a new, separate registration process to facilitate medical marijuana research.

Specifically, it directs the Drug Enforcement Administration to register (1) practitioners to conduct medical marijuana research, and (2) manufacturers and distributors to supply marijuana for such research.

Additionally, the Department of Health and Human Services must continue to produce marijuana through the National Institute on Drug Abuse Drug Supply Program and implement a specialized process for supplying marijuana products available through state-authorized marijuana programs to researchers until manufacturers and distributors can provide a sufficient supply of marijuana for medical research.

What's happening now December 18, 2020

Read twice and referred to the Committee on the Judiciary.

Committees of jurisdiction 5